Thermo Fisher Scientific-Sponsored Pharmacogenomics Podcast Series
This is Dr. Becky Winslow from the Precision Health and PGx podcast. We are honored to have produced and hosted a special pharmacogenomics series sponsored by Thermo Fisher Scientific, which covers the hottest topics in pharmacogenomics today.
This is a must-listen series for any entity interested in the current pharmacogenomics landscape.
Listeners will hear from industry experts such as:
Dr. Jeremy Stuart, Senior Director, Genetics & Genomics at Medical University of South Carolina Health
Hilary Goeckner, Director of State & Local Campaigns - Access to Care of the American Cancer Society Cancer Action Network
And
Dr. Megan Landsverk, Scientific Director, MolDX® and Chief Science Officer, Palmetto GBA®
Click on the images of the episodes below to discover why FeedSpot ranked The Precision Health and PGx Podcast sixteenth out of thousands of Pharmaceutical podcasts for its relevancy, authority, social media followers, and freshness!
Be sure to tune in to this episode of the Precision Health and PGX Podcast as Dr. Becky Winslow, Dr. Behnaz Sarrami, and Dr. Jeremy Stuart, Senior Director of Genetics & Genomics at Medical University of South Carolina Health, discuss pharmacists' value as employees in clinical pharmacogenomics testing laboratories. Having employed pharmacists in his laboratories, Dr. Stuart will provide first-hand examples to illustrate how pharmacists have benefited his laboratories. Dr. Winslow and Dr. Sarrami will also share their real-world experiences working for clinical pharmacogenomics laboratories to help the laboratory achieve its goals.
This episode is a must-listen for laboratories vested in pharmacogenomics testing's financial success.
After listening to this episode, the learner will be able to describe the responsibilities and roles pharmacists fulfill in clinical labs, name specific real-world examples that illustrate pharmacists’ contributions to pharmacogenomics in the clinical laboratory, and name education, training, and work experiences that prepare pharmacists to assume advanced practice roles in clinical laboratories.
Dr. Jeremy Stuart has extensive experience in the life science industry. He specializes in commercial operations, technology development and transfer, manufacturing design, and laboratory-developed tests (LDTs) validation. He is the Senior Director of Genetics & Genomics at the Medical University of South Carolina Health. He recently departed his position as Chief Scientific Officer and Laboratory Director for Precision Genetics. Dr. Stuart was part of the senior management team that completed a management buyout of Lab21 Inc. to form Selah Genomics and the subsequent sale of Selah to EKF. Dr. Stuart led the development and validation of Selah’s molecular assays and oversaw their clinical studies. Dr. Stuart was also a member of the Agencourt Personal Genomics team, where he co-developed the SOLiD next-generation sequencing technology that Applied Biosystems subsequently acquired. Before entering the industry, Dr. Stuart completed his postdoctoral work at the Harvard School of Public Health. He earned his master’s degree in Toxicology from the University of Minnesota and his doctorate in Genetics & Complex Diseases from Harvard University.
Be sure to tune in to this episode of the Precision Health and PGX Podcast as Dr. Becky Winslow and Dr. Megan Landsverk, Scientific Director of MolDX® and Chief Science Officer of Palmetto GBA®, discuss how laboratories may overcome the challenges they face earning MolDX® coverage and reimbursement for their clinical pharmacogenomics tests. Specific to coverage determinations, the PGx veterans discuss test design, post-genotype translations, and technical assessments. Specific to reimbursement, the duo discusses evidence-based reporting and complete claim submissions. Also discussed is the importance of labs clearly defining intended use populations for tests and academic partnerships.
Dr. Megan Landsverk is a Science Officer for Palmetto GBA®, a Medicare Administrative Contractor (MAC), and a Science Director for the Molecular Diagnostic Services (MolDX®) program developed to identify and establish coverage and reimbursement for molecular diagnostic services on behalf of Medicare. Dr. Landsverk received her PhD in Biochemistry and Molecular Biology from Baylor College of Medicine and postdoctoral training in Medical Genetics at the University of Washington. She is a board-certified molecular geneticist, having completed her molecular genetics fellowship at Baylor College of Medicine. She has held multiple academic faculty positions and has numerous publications in genetics. Before joining Palmetto GBA®, she was a clinical laboratory director in academic, hospital, and commercial clinical laboratories. She has experience in several genetic specialties, including rare diseases (pediatric and adult), cancer (somatic and inherited), and pharmacogenetics.